GlassScriptPhysician profile
Stephanie Stone
NPI 1548579972
$4,075.49
in general payments reported to CMS, 2019-2025
27 companies · $871 in 2025
The $871 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $261 · 2022: $1,653 · 2023: $602 · 2024: $688 · 2025: $871.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,161.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $1,511.98 | 2022 | |
| Exact Sciences Corporation | $303.80 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amgen INC. | $285.52 | 2023-2025 | Repatha, Repatha, Otezla |
| Abbvie INC. | $282.61 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $234.42 | 2023-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $228.53 | 2023-2025 | Mounjaro, Zepbound, Trulicity |
| Pfizer INC. | $225.78 | 2021-2025 | |
| Glaxosmithkline, LLC. | $171.64 | 2021-2025 | Shingrix, Arexvy, Bexsero |
| Novo Nordisk INC | $140.61 | 2021-2025 | Ozempic, Rybelsus |
| Abbott Laboratories | $98.44 | 2023-2024 | Freestyle Libre 3, Eterna |
| Merck Sharp & Dohme LLC | $68.53 | 2021-2025 | Capvaxive, Gardasil 9, Rotateq |
| Hologic Sales and Service, LLC | $64.24 | 2022-2025 | Aptima |
| Sumitomo Pharma America, INC. | $60.69 | 2024-2025 | Gemtesa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.84 | 2022-2023 | Tradjenta, Jardiance |
| Esperion Therapeutics, INC. | $38.51 | 2025 | Nexletol |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $38.45 | 2021-2025 | Paragard T 380a |
| Madrigal Pharmaceuticals | $36.25 | 2025 | Rezdiffra |
| Bausch Health US, LLC | $35.53 | 2021-2023 | Wellbutrin, Aplenzin |
| Edwards Lifesciences Corporation | $33.18 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Inari Medical, INC. | $28.01 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Otsuka America Pharmaceutical, INC. | $26.47 | 2024 | Rexulti |
| Exeltis, USA INC. | $24.58 | 2023 | Slynd |
| Acella Pharmaceuticals, LLC | $20.17 | 2024 | NP Thyroid 60 |
| Phathom Pharmaceuticals, INC. | $17.11 | 2024 | Voquezna |
| Astellas Pharma US INC | $17.01 | 2021 | |
| Corium, LLC | $16.87 | 2023 | Azstarys |
| Tolmar, INC. | $14.72 | 2025 | Jatenzo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Stone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.